RedHill Biopharma Ltd is a specialty biopharmaceutical company engaged in the development and commercialization of late clinical-stage, proprietary, and small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer. This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:RDHL.
$0.96 -0.06 (-6.19%)
As of 05/24/2022 15:40:15 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.